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Highlights 
 Sodium selenite treatment reduces lipid accumulation in mature adipocytes in vitro
 Adipogenesis increased cellular ROS levels while decreasing Gpx1 gene expression
 Adipogenesis increased Dio2 gene expression
 Selenite prevented adipogenesis through increased Gpx1, Selenow, Selenop expression




Objective: This study aimed to assess the effect of the micronutrient selenium, as inorganic 
selenite, on adipocytes differentiation and to identify underlying molecular mechanisms, while 
advancing understanding of basic cellular mechanisms associated with adipogenesis.  
Methods: 3T3-L1 murine preadipocytes were used to investigate the effect of sodium selenite 
(Na2SeO3) on cell viability (MTT assay) in preadipocytes, lipid accumulation (Oil Red O 
staining) and intracellular reactive oxygen species (ROS, NBT assay) in mature adipocytes, in 
addition to explore molecular mechanisms via gene expression analyses (RT-qPCR), pre and post 
differentiation.  
Results: Selenite (100, 200, 400nM) significantly decreased lipid accumulation during 
differentiation compared to untreated adipocytes (P<0.05, 0.001, 0.01, respectively). Pre-
adipocytes exposure (48h) to selenite caused an increase in glutathione peroxidase 1 (Gpx1) gene 
expression in a dose-dependent manner. Adipogenesis significantly increased intracellular ROS 
levels (P<0.05) while decreasing gene expression of antioxidant enzymes (Gpx1, P<0.05) and 
significantly increasing gene expression of regulators of lipid catabolism (type II iodothyronine 
deiodinase, Dio2, P<0.01) and of markers of differentiation (e.g. selenium-binding protein 1, 
Selenbp1, peroxisome proliferator activated receptor gamma, Pparg, CCAAT/enhancer binding 
protein alpha, Cebpa, and fatty acid binding protein 4, Fabp4) compared to pre-adipocytes 
(P<0.01, 0.01, 0.01 and 0.001, respectively). Selenite exposure (200nM) caused a significant 
increase in Gpx1, selenoprotein W (Selenow), selenoprotein P (Selenop) gene expression in 
differentiated adipocytes compared to untreated ones (P<0.01, 0.001, 0.05, respectively) with a 
significant decrease in heme oxygenase 1 (Ho-1), cyclooxygenase 2 (Cox2), Dio2 and Fabp4 
gene expression (P<0.001, 0.05, 0.05 and 0.01, respectively). 
Conclusions: Selenium, as selenite, prevented adipogenesis through increasing antioxidant 
selenoproteins expression, leading to decreased inflammatory markers and, subsequently, to 
decrease in differentiation and lipid deposition. These findings, if demonstrated in vivo, could 
provide valuable data for novel dietary approaches to prevent obesity. 
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peroxidase 1; GPX2: glutathione peroxidase 2; GPX4: glutathione peroxidase 4; HO-1: heme 
oxygenase 1; IBMX: 3-isobutyl-1-methylxanthine; MDI: hormone mixture; MTT: Bromide 3-
[4,5-dimethylthiazol-2-yl]-2,5-difeniltetrazol; Na2SeO3: sodium selenite; NAC: N-acetyl-L-
cysteine; NBCS: new born calf serum; NBT: nitroblue tetrazolium; NRF2: nuclear factor 
erythroid 2 related factor 2; ORO: Oil Red O dye; PBS: phosphate-buffered saline; PPARG: 
peroxisome proliferator activated receptor gamma; ROS: reactive oxygen species, Se: selenium; 
SELENBP1: selenium-binding protein 1; SELENOP: selenoprotein P; SELENOS: selenoprotein 
S; SELENOW: selenoprotein W; TXNRD1: Thioredoxin reductase 1; TXNRD2: Thioredoxin 
reductase 2; UCP2: uncoupling protein 2. 
Introduction 
Obesity is a chronic and progressive disease that affects a significant proportion of the world’s 
population. It is a major risk factor for type 2 diabetes, metabolic syndrome and hypertension, 
stroke and cardiovascular disease [1-3]. Previous clinical studies have identified a correlation 
between obesity and systemic oxidative stress [4], whereas preliminary studies carried out in 
animal or in vitro models acknowledged a significant role of antioxidant enzymes in regulating 
adipogenesis [5, 6].  
Adipogenesis plays a crucial role in the increase of adipose mass and obesity development [7]. 
During this process, cells undergo biochemical and morphological changes, which are partly 
associated with or driven by oxidative stress. Oxidative stress plays, therefore, a promoting role 
in lipid accumulation as previously demonstrated in in vitro studies where both oxidative and 
endoplasmic reticulum (ER) stress induced lipid droplet accumulation in a hepatoma cell line 
(Hep-G2) and cultured hepatocytes [8-10]. Moreover, reactive oxygen species (ROS) have been 
shown to augment adipocytes differentiation and lipid accumulation in 3T3-L1 cells, a widely 
used cell model to study basic cellular mechanisms associated with adipogenesis and obesity, due 
to their potential to differentiate from fibroblasts into mature adipocytes [11]. Maintenance of 
redox homeostasis is important for adipogenesis regulation and obesity prevention and is 
regulated through numerous genes including nuclear factor erythroid 2 related factor 2 (Nrf2), 
heme oxygenase 1 (Ho-1), glutathione S-transferase, superoxide dismutase, catalase and 
selenoproteins such as glutathione peroxidases (Gpxs) and thioredoxin reductase 1 (Txnrd1) [12].  
Deficiencies in micronutrients such as vitamins and trace elements can contribute to the 
development of impaired antioxidant defences potentially involved in the pathogenesis of obesity 
and associated diseases by modulating redox homeostasis. Lower selenium and zinc levels have 
been observed in obese children [13, 14], especially with central obesity and morbidly obese 
patients present magnesium, selenium, iron, and zinc deficiencies [15]. These results may suggest 
that, in the obese population, inadequate concentrations of vitamins and minerals may cause the 
observed impaired antioxidant defence [5]; however further studies are required to elucidate 
associations between micronutrients levels and obesity. Although supplementation with minerals 
and vitamins may be beneficial, in relation to selenium supplementation, a recent review of the 
literature showed a counterpoint about high doses of selenium and its relationship to the 
development of obesity in up-regulation of adipocyte-specific genes [16]. Therefore, 
understanding the participation of selenium in the redox metabolism and adipocytes 
differentiation is a promising area of research and of clinical relevance, and essential for safe and 
targeted dietary guidance. Moreover, the high expression of selenium-containing proteins in 
adipose tissue in both healthy and obese conditions [17, 18] is indicative of the significant role of 
selenium in adipocytes biology, and warrant further research. 
Selenium (Se) is an essential micronutrient that has potent anti-oxidative and anti-inflammatory 
properties [19, 20]. Selenium acts mainly through selenocysteine-containing proteins and is 
incorporated into selenocysteine amino acid in the catalytic site of enzymatically active 
selenoproteins, thus representing an essential component of selenoproteins [21, 22]. Several 
selenoproteins such as thioredoxin reductases isoenzymes (TXNRD1 and TXNRD2), glutathione 
peroxidases isoenzymes (GPX1-4), selenoprotein P (SELENOP), selenoprotein S (SELENOS) 
and selenoprotein W (SELENOW) play an important role in the cellular defence systems against 
oxidative stress [23, 24]. SELENOW has been shown to have an important role in protecting 
immune organs from inflammatory injury through regulation of inflammation-related genes [25]. 
More specifically to adipose tissue and in addition to the above mentioned selenoproteins, 
iodothyronine deiodinases (DIO) are highly expressed, and their expression and activity is 
modulated by adipose tissue remodelling in obesity. In particular, increased expression of type II 
iodothyronine deiodinase (DIO2) has been tightly associated with reduced lipid catabolism and 
mitochondrial dysfunction [26]. Even if not a selenoprotein, selenium-binding protein 1 
(SELENBP1) has been recently shown to be a marker of mature adipocytes and to catalyse the 
oxidation of methanethiol into hydrogen peroxide and hydrogen sulphide, which are key 
signalling molecules for adipocyte differentiation [27]. 
The micronutrient selenium has been suggested to have anti-inflammatory and anti-oxidative 
properties, through its incorporation in selenoproteins, and the exact mechanisms by which 
selenium may affect adipogenesis are not clear. The current study used 3T3-L1 cells to advance 
the understanding of the basic cellular mechanisms associated with adipogenesis and aimed to 
identify how selenium may affect differentiation into mature adipocytes and the underlying 
molecular mechanisms. The effect of selenium, as inorganic selenite, on gene expression of 
several selenoproteins (e.g. Gpx1, Gpx4, Selenop, Selenos, Selenow, Dio2), markers of adipocytes 
differentiation (e.g. Selenbp1, peroxisome proliferator activated receptor gamma (Pparg), 
CCAAT/enhancer binding protein alpha (Cebpa) and fatty acid binding protein 4 (Fabp4)), redox 
and energy metabolism regulators (e.g. Nrf2, Ho-1, and uncoupling protein 2 (Ucp2)), and 
inflammation (e.g. cyclooxygenase 2 (Cox2)) has been determined in 3T3-L1 pre- and mature 
adipocytes cultured in different concentrations of selenium.  
Methods 
Cell culture 
3T3-L1 preadipocytes were purchased from European Collection of Authenticated Cell Cultures 
(ECACC, distributed via Sigma Aldrich, UK; ECACC number: 86052701, lot: 130030) and 
cultured at 37ºC/8% CO2 in Dulbecco's modified Eagle's medium (DMEM + Glutamax, 
containing 4.5g/L glucose + pyruvate (Gibco cat n 31966-021), supplemented with 1% 
penicillin/streptomycin (Gibco, cat n 15140-122) and 10% new born calf serum (NBCS, Gibco, 
cat n 26010). 3T3-L1 cells were used until passage 10. 
Cell viability assay 
To evaluate the effect of different concentrations of sodium selenite (Na2SeO3) (50, 100, 200, 
400nM) on cell viability, MTT (Bromide 3-[4,5-dimethylthiazol-2-yl]-2,5-difeniltetrazol) assay 
was used. The assay is based on the presence of mitochondrial enzymes in viable cells that reduce 
MTT to produce purple formazan crystals.  





in 96 well plates and incubated for 24 hours before changing medium containing different 
Na2SeO3 concentrations (50, 100, 200, 400nM). After 48 hours, treatment media were removed 
and 100μL MTT (1mg/mL in complete medium (DMEM medium supplemented with 10% 
NBCS)) was added to each well and incubated for 4 hours at 37ºC in the dark. MTT solution was 
removed, and 200μL dimethyl sulfoxide was added to each well to solubilize formazan crystals 
for 30 minutes in the dark on a shaker. Absorbance was then measured at 560nm. 
Cell differentiation and treatment protocols 
Differentiation of the cells was carried out with two different protocols as described and 
summarised in the diagram reported in Figure 1. 
Protocol 1: Cells, seeded at a concentration of 2x10
4
 cells/well in 24 wells plates, were allowed to
grow to confluence. Forty-eight hours post confluence (Day 0), cells were treated with DMEM 
medium containing a hormone mixture (MDI) and 10% fetal bovine serum (FBS, Gibco, cat n 
10500-064) for 2 days. MDI mixture was composed of 0.5mM 3-isobutyl-1-methylxanthine 
(IBMX), 1μM dexamethasone, 1μg/mL insulin and 1µM Rosiglitazone. On day 2, the culture 
medium was then replenished with DMEM (10% FBS) supplemented only with 1μg/mL insulin 
for 5 days. On day 7, the culture medium was replenished with DMEM (10% FBS) for 2 days 
(according to published protocol [29]).  
Protocol 2: Cells were cultured similarly to protocol 1 apart from the following changes: MDI 
mixture was composed of 0.5mM IBMX, 1μM dexamethasone, 1μg/mL insulin only; duration of 
incubation with insulin medium was reduced to 3 days and subsequently replenished, at Day 5, 
with DMEM (10% FBS) for 2 days (according to published protocol [30]). 
Different treatments were used during the differentiation protocol including 10mM N-acetyl-L-
cysteine (NAC, positive control) and different concentrations of Na2SeO3 (100, 200, 400nM) as 
reported in the diagram below (Figure 1).  
Figure 1: Differentiation and treatment protocols used in the study.  
FBS: fetal bovine serum; MDI: hormone mixture, NAC: N-acetyl-L-cysteine; Se: sodium selenite 
Lipid content 
To assess the progress of differentiation, lipid accumulation was measured using Oil Red O 
(ORO) dye. ORO staining was performed according to the following protocol [31]: at the end of 
differentiation protocol, the medium was removed, and cells washed with phosphate-buffered 
saline (PBS) before incubating cells with 10% formalin buffered saline for 30 minutes. Cells 
were washed 2 times with PBS and subsequently incubated with 60% isopropanol for 5 minutes. 
Isopropanol solution was removed, and cells were incubated with ORO working solution (0.5% 
stock solution mixed with Milli-Q water at a ratio of 3:2) for 1 hour at room temperature in the 
dark. Excess ORO was removed by washing three times with double-distilled water. Isopropanol 
was added to each well to solubilize ORO and incubated for 15 minutes, in the dark, on a shaker. 
Absorbance was then measured at 590 nm. The % ORO staining was calculated relative to the 
control (differentiated adipocytes).  
Intracellular ROS levels 
To assess the amount of ROS present within cells during differentiation and after selenium 
treatment, the nitroblue tetrazolium (NBT) assay was performed according to the following 
protocol [32] with small modifications. In brief, at the end of the differentiation protocol, the 
medium was removed, and replaced with 0.5 ml NBT solution (0.2% NBT in PBS) per well. 
Cells were incubated at 37°C, in the dark, for 90 minutes. NBT solution was then removed and 
cells were washed twice with methanol and left to air dry for few minutes. The NBT deposited 
inside the cells was then dissolved, first by adding 240µL 2M KOH to solubilize cell membranes 
and then by adding 280µL DMSO to dissolve blue formazan with gentle shaking for 20 min at 
room temperature, in the dark. Absorbance was then measured at 630 nm. The % NBT staining 
was calculated relative to the control (differentiated adipocytes). 
Gene expression 
RNA was extracted from either pre-adipocytes treated for 48 hours with different concentrations 
of sodium selenite or from mature adipocytes treated with different concentrations of sodium 
selenite during the differentiation stages.  
Total RNA was isolated from cells using the TRI Reagent
TM
 solution (Ambion, UK) according to
manufacturer’s guidelines. The RNA pellet was then dissolved in nuclease-free water, and RNA 
concentration and purity were measured by measuring absorbance at 260/280nm. One hundred ng 
of total RNA was used for cDNA synthesis using SuperScript III Reverse Transcriptase 
(Invitrogen, UK) and random hexamers as primers (Promega, UK).  
Real-time PCR was performed using the SYBR Green PCR Master Mix kit (Primer Design, UK) 
as recommended by the manufacture, and 0.25µM of forward and reverse primers. Primers were 
designed using Pubmed (Entrez Gene) and premier Biosoft, USA (Table 1). mRNA levels were 
quantified by using the comparative CT method (2
−ΔΔCT
 method). The data were normalised to β2
microglobulin (B2m) RNA to account for differences in reverse transcriptase efficiencies and the 
amount of template in the reaction mixtures. 
Table 1: Sequence of the primers used for qPCR 
B2m: Beta 2 microglobulin; Cebpa: CCAAT/enhancer binding protein alpha; Cox2: cyclooxygenase 2; Dio2: Type II iodothyronine deiodinase; Fabp4: fatty acid 
binding protein 4; Gpx1: Glutathione peroxidase 1; Gpx4: Glutathione peroxidase 4; Ho-1: heme oxygenase 1; Nrf2: nuclear factor erythroid 2 related factor 2; 
Gene 
Forward Primer Reverse Primer 
Product size 
(bp) 
B2m TGGTCTTTCTGGTGCTTGTCT GGATTTCAATGTGAGGCGGG 153 
Cebpa TGAAGGAACTTGAAGCACA TCAGAGCAAAACCAAAACAA 201 
Cox2 [33] AAGCGAGGACCTGGGTTCA AAGGCGCAGTTTATGTTGTCTGT 96 
Dio2 ATGGGACTCCTCAGCGTAGAC ACTCTCCGCGAGTGGACTT 150 
Fabp4 ATGATCATCAGCGTAAATGG GCCTTTCATAACACATTCCA 245 
Gpx1 CAGGAGAATGGCAAGAATGA GAAGGTAAAGAGCGGGTGAG 135 
Gpx4 [34] GCTGGGAAATGCCATCAAATGGA ACGGCAGGTCCTTCTCTATCAC 115 
Ho-1 CGCTACCTGGGTGACCTCTC TGTTTGAACTTGGTGGGGCT 134 
Nrf2 GGAAGTGTCAAACAGAACGGC GACCAGGACTCACGGGAACT 154 
Pparg GTCTGTGGGGATAAAGCATC CTGATGGCATTGTGAGACAT 205 
Selenbp1 [27] TGAGCCTCTGCTCGTTCC TGGACCACACTTTGTGCATT 88 
Selenop[34] CTCATCTATGACAGATGTGGCCGT AAGACTCGTGAGATTGCAGTTTCC 137 
Selenos [34] GAAGGCCTCAGGAAGAAGATGGT GTCTCCAGGAGCAGGTTCCA 137 
Selenow [34] ATGCCTGGACATTTGTGGCGA GCAGCTTTGATGGCGGTCAC 153 
Ucp2 TAAGTGTTTCGTCTCCCAGCC GCTTCTCTAAAGGTGTCTCGTTC 99 
Pparg: peroxisome proliferator activated receptor gamma; Selenbp1: selenium-binding protein 1; Selenop: selenoprotein P; Selenos: selenoprotein S; Selenow: 
selenoprotein W; Ucp2: uncoupling protein 2 
Statistical analysis 
All results were expressed as mean ± standard error of the mean (Mean ± SE). Student t-test was 
used for analysing statistically significant differences between two groups. One-way analysis of 
variance (ANOVA) followed by Tukey or Dunn’s tests, according to the distribution of the data, 
was also used for analysing statistically significant differences between groups. P values of <0.05 
were considered significant. Statistical analysis was carried out using GraphPad Prism Software 
version 7.0 (GraphPad Software, CA, USA). 
Results 
Selenite affects preadipocytes cell viability at high concentrations 
Concentrations of 50, 100 and 200nM sodium selenite did not affect cell viability when tested 
against 3500 or 5000 cells/well whereas 400nM sodium selenite induced a significant decrease in 
cell viability (21%, P<0.01, and 14%, P<0.05, when cells were seeded at 3500 and 5000 
cells/well, respectively) (Figure 2).  
Figure 2: Effect of sodium selenite on cell viability. Cell viability was assessed in 3T3-L1 cells 
at a concentration of either (A) 3500 cells/well or (B) 5000 cells/well, after exposure to different 
concentrations of Na2SeO3 (50, 100, 200 and 400nM) for 48 hours. Data are expressed as % of 
untreated cells (control). n=6 experiments for A and n=7 experiments for B. * P<0.05, ** P<0.01 
vs control.  
MTT: Bromide 3-[4,5-dimethylthiazol-2-yl]-2,5-difeniltetrazol; Se: sodium selenite 
Selenite supplementation during differentiation affects lipid accumulation in a protocol-
dependent manner 
According to protocol 1, which includes the use of rosiglitazone in the differentiation process, 
different doses of sodium selenite did not cause significant changes in lipid accumulation whereas 
10mM NAC (positive control) caused a 29% significant decrease in ORO staining compared to 
untreated differentiated cells (Control) (P<0.01) (Figure 3 A). NAC was used as a positive 
control for adipogenesis inhibition as it is a well-known strong antioxidant and has been used to 
hinder 3T3-L1 differentiation in several studies [35-37]. NAC was used as a positive control in 
cytotoxicity assays without affecting cell viability at the concentrations tested (data not shown).   
Whilst using protocol 2, the addition of 10mM NAC, 100, 200 or 400nM Na2SeO3, during all 
stages of differentiation, induced a significant decrease (13, 14, 19, 19%, respectively, P<0.05, 
0.05, 0.001, 0.01, respectively) in ORO staining compared to untreated differentiated cells 
(Control) (Figure 3B).  
Figure 3: Effect of sodium selenite on lipid accumulation. Lipid accumulation was detected in 
differentiated cells by ORO staining (A) in the presence of rosiglitazone and (B) in its absence in 
MDI, after incubation with 10mM NAC, and 100, 200 and 400nM sodium selenite. Water was 
used to prepare sodium selenite solutions and used as vehicle control (A). Data are expressed as 
% of untreated differentiated cells (Control) n=6 experiments for each A and B. * P<0.05; ** 
P<0.01 *** P<0.001 vs control group.  
NAC: N-acetyl-L-cysteine; ORO: oil red O dye; Se: sodium selenite 
Sodium selenite differentially affects Gpx1 and Gpx4 gene expression in preadipocytes 
The effect of 48 hours treatment of preadipocytes with different doses of Na2SeO3 on the 
expression of Gpx1 and Gpx4 genes was investigated. Sodium selenite induced an increase in 
Gpx1 expression in a dose-dependent manner (Figure 4A). In particular, 50, 200 and 400nM 
sodium selenite caused a significant increase in Gpx1 expression compared to untreated cells: 
Gpx1 expression increased by 1.4 fold (P<0.05), 1.7 fold (P<0.01) and 1.9 fold (P<0.05) in cells 
incubated with 50, 200 and 400nM Na2SeO3, respectively. No significant changes in Gpx4 gene 
expression were observed with different doses of sodium selenite (Figure 4B).  
A 
B 
Figure 4: Effect of sodium selenite on Gpx1 and Gpx4 expression in preadipocytes. Gpx1 (A) 
and Gpx4 (B) mRNA abundance in preadipocytes exposed to 50, 100, 200nM and 400nM sodium 
selenite for 48-hours. Data are expressed as fold change compared to untreated preadipocytes 
(Control). (n=4 experiments, * P<0.05; ** P<0.01 vs control group). 
Gpx1: glutathione peroxidase 1; Gpx4: glutathione peroxidase 4; Se: sodium selenite 
Sodium selenite supplementation during differentiation affects intracellular ROS levels 
As 200nM Na2SeO3 induced a significant decrease in lipid accumulation (Figure 3B) without 
causing a significant change in cell viability (Figure 2A and B), 200nM Na2SeO3
supplementation was chosen as the optimal concentration to study effects ROS levels within cells 
and, subsequently, on gene expression of markers of antioxidant status, redox and energy 
metabolism regulators, and inflammation. The differentiation process caused a 37% increase 
(P<0.01) in ROS levels measured by NBT assay (Figure 5) compared to undifferentiated cells 
cultured for the same length of time as in the differentiation protocol (protocol 2, 7 days); 
whereas addition of 200nM Na2SeO3 during the differentiation process (day 0-7) caused a 
significant decrease in ROS (20%, P<0.05) compared to untreated adipocytes. 
A B 
Figure 5: Effect of sodium selenite on intracellular ROS levels. ROS levels were detected in 
undifferentiated (Preadipocytes), differentiated (Adipocytes) and differentiated cells 
supplemented with 200nM sodium selenite (200nM Se Adipocytes) by NBT staining. Data are 
expressed as % of untreated differentiated cells (Adipocytes) n=3 experiments. * P<0.05; ** 
P<0.01 vs adipocytes.  
NBT; nitroblue tetrazolium; Se: sodium selenite 
Sodium selenite differentially affects expression of markers of antioxidant status in preadipocyte 
Exposure of 3T3-L1 preadipocytes for 7 days to 200nM Na2SeO3 induced a significant increase 
in Selenow mRNA (P<0.05) compared to untreated cells, but no other significant differences 
were observed for any of the genes tested (Figure 6). 
Figure 6: Effect of 7 days exposure to 200nM sodium selenite on gene expression in 
preadipocytes. Gpx1, Gpx4, Selenow, Selenop, Selenos, Nrf2, Ho-1, Cox2, Dio2, Ucp2, 
Selenbp1; Pparg, Cebpa and Fabp4 gene expression in preadipocytes exposed to 200nM sodium 
selenite for 7 days (Pre-adipocytes + 200nM Se). Data are expressed as fold change compared to 
untreated preadipocytes (black bar). n=3-7 experiments, * P<0.05 vs preadipocytes. 
Cebpa: CCAAT/enhancer binding protein alpha; Cox2: cyclooxygenase 2; Dio2: type II iodothyronine deiodinase; 
Fabp4: fatty acid binding protein 4; Gpx1: glutathione peroxidase 1; Gpx4: glutathione peroxidase 4; Ho-1: heme 
oxygenase 1; Nrf2: nuclear factor erythroid 2 related factor 2; Pparg: peroxisome proliferator activated receptor 
gamma; Selenbp1: selenium-binding protein P1; Selenop: selenoprotein P; Selenos: selenoprotein S; Selenow: 
selenoprotein W; Ucp2: uncoupling protein 2. Se: sodium selenite 
Differentiation affects expression of markers of antioxidant status and energy metabolism 
regulators 
The differentiation protocol that involved the use of MDI without rosiglitazone and exposure to 
insulin for 3 days was used to further investigate the molecular changes that occur during 
differentiation on biomarkers of adipocytes differentiation, antioxidant status, redox metabolism 
regulators and inflammation. 
The expression of Gpx1 was significantly decreased (0.4 fold, P<0.05) in differentiated cells 
compared to preadipocytes (Figure 7), whereas the expression of Selenow had a similar 
decreasing trend without reaching significant difference (0.4 fold, P=0.21) (Figure 7). Expression 
of Dio2, Selenbp1, Pparg, Cebpa and Fabp4 were significantly increased in differentiated cells 
compared to preadipocytes (1.7 fold, P<0.05; 2.0 fold, P<0.01; 2.1 fold, P<0.01; 2.4 fold, P<0.01; 
112 fold, P<0.001, respectively). The expression of Cox2 showed a similar increasing trend in 
differentiated cells compared to preadipocytes (1.9 fold), without reaching significant difference 
(Figure 7).
Figure 7: Effect of differentiation on gene expression. Gpx1, Gpx4, Selenow, Selenop, Selenos, 
Nrf2, Ho-1, Cox2, Dio2, Ucp2, Selenbp1, Pparg, Cebpa and Fabp4 gene expression in 
adipocytes. Data are expressed as fold change compared to untreated preadipocytes (black bar). 
n=3-7 experiments, * P<0.05; *** P<0.001 vs preadipocytes. 
Cebpa: CCAAT/enhancer binding protein; Cox2: cyclooxygenase 2; Dio2: type II iodothyronine deiodinase; Fabp4: 
fatty acid binding protein 4; Gpx1: glutathione peroxidase 1; Gpx4: glutathione peroxidase 4; Ho-1: heme oxygenase 
1; Nrf2: nuclear factor erythroid 2 related factor 2; Pparg: peroxisome proliferator activated receptor gamma; 
Selenbp1: selenium-binding protein P1; Selenop: selenoprotein P; Selenos: selenoprotein S; Selenow: selenoprotein 
W; Ucp2: uncoupling protein 2. 
Sodium selenite supplementation during differentiation affects expression of markers of 
antioxidant status, redox, and energy metabolism regulators, and inflammation in adipocytes 
Addition of 200nM Na2SeO3 during the differentiation process (day 0-7) caused a significant 
increase in Gpx1, Selenow, Selenop mRNA expression (1.6, 3.8, 1.4 fold, P<0.01, 0.001, 0.05, 
respectively) compared to non-supplemented adipocytes (Figure 8A). Selenite supplementation 
did not affect Gpx4 (1.7 fold, P=0.37) or Selenos gene expression. However, it had a significant 
effect on Ho-1 and Cox2 gene expression by reducing their mRNA levels (0.4 and 0.5 fold, 
respectively), when compared to non-supplemented adipocytes (P<0.001, 0.05) (Figure 8B). Nrf2 
expression was not affected by selenium supplementation. 
Concerning biomarkers of energy metabolism and adipocytes differentiation, sodium selenite 
supplementation reduced Dio2 gene expression (0.3 fold, P<0.05) without affecting Ucp2 gene 
expression. The expression of Fabp4 gene was significantly reduced by the addition of sodium 
selenite (0.3 fold, P<0.01), and a similar trend was observed for Cebpa expression (0.5 fold), 
without reaching statistical difference (Figure 8C). Selenbp1 expression was not affected by 
selenium supplementation. 
Figure 8: Effect of 7 days exposure to 200nM sodium selenite during differentiation on gene 
expression. Expression of A) Gpx1, Gpx4, Selenow, Selenop, Selenos; B) Nrf2, Ho-1, Cox2; and 
C) Dio2, Ucp2, Selenbp1, Pparg, Cebpa and Fabp4 in untreated adipocytes (Adipocytes) and
adipocytes exposed to 200nM sodium selenite for 7 days (200nM Se adipocytes). Data are
expressed as fold change compared to untreated adipocytes (Adipocytes). n=3-7 experiments, *
P<0.05, ** P<0.01, *** P<0.001 vs adipocytes.
Cebpa: CCAAT/enhancer binding protein; Cox2: cyclooxygenase 2; Dio2: type II iodothyronine deiodinase; Fabp4: 
fatty acid binding protein 4; Gpx1: glutathione peroxidase 1; Gpx4: glutathione peroxidase 4; Ho-1: heme oxygenase 
1; Nrf2: nuclear factor erythroid 2 related factor 2; Pparg: peroxisome proliferator activated receptor gamma; 
Selenbp1: selenium-binding protein P1; Selenop: selenoprotein P; Selenos: selenoprotein S; Selenow: selenoprotein 
W; Ucp2: uncoupling protein 2. Se: sodium selenite. 
Discussion 
Obesity has been proposed to be modulated by oxidative stress and inflammation[5], whereas the 
micronutrient selenium has been suggested to have anti-inflammatory and anti-oxidative 
properties, which might be beneficial in preventing or reducing adipogenesis, therefore 
contributing to the management of obesity. This study showed, for the first time, supplementation 
C 
A B 
with sodium selenite to reduce adipocyte differentiation and lipid deposition in 3T3-L1 cells. 
Interestingly, the effects of selenium, as selenite, depended on the presence of rosiglitazone in 
induction medium, with sodium selenite having no significant effect on lipid accumulation in 
presence of rosiglitazone but having sodium selenite at different concentrations (100, 200 and 
400nM) significantly decreased lipid deposition in differentiated adipocytes in the absence of 
rosiglitazone. These findings are consistent with the studies of Kobayashi et al. (2009), which 
used a different treatment protocol with selenium and stated that the presence of rosiglitazone in 
the medium inhibited the treatment potency of selenium [38] and Zhao et al. (2019) which 
suggested that rosiglitazone does not cause the differentiation process but it can accelerate it[11]. 
In order to identify the molecular mechanisms involved, it is important to understand how 
selenium supplementation affects gene expression of selenoproteins with anti-oxidant properties 
such as GPX1, GPX4, SELENOW, SELENOP and SELENOS, not only in preadipocytes but 
also in mature adipocytes. Supplementation of preadipocytes with 200nM sodium selenite for 48 
hours only increased Gpx1 expression (Figure 4A), whereas Selenow expression was increased 
after 7 days (Figure 6). No effect was observed on Gpx4, Selenop, Selenos and Dio2 expression. 
Gpx1 expression being more affected than Gpx4 expression may be explained by differences in 
Gpx1 mRNA stability and biosynthesis compared to Gpx4, which is expressed more stably. Gpx1 
and Gpx4 expression are differentially affected by selenium deficiency in liver and colon of rats 
and mice, respectively, due to increased stability of Gpx4 mRNA and biosynthesis hierarchy [39]. 
GPX1 is considered to rank lowest in this hierarchy since it rapidly declines upon selenium 
deprivation and is re-synthesized with considerable delay upon selenium repletion [40-42]. Other 
selenoproteins, such as GPX4, GPX2, deiodinases, or thioredoxin reductases rank high in the 
hierarchy. In general, the ranking of selenoproteins parallels the stability of their mRNA. 
However, no data are available on how selenium deficiency or supplementation may affect 
selenoproteins’ hierarchy and mRNA stability in adipose tissue, and this is the first study 
suggesting a more rapid response of Gpx1 and Selenow gene to selenium supplementation for 2 
or 7 days, respectively.  
The effect of selenium supplementation, as selenite, was also assessed on the expression of 
markers of adipocytes differentiation, redox, and energy metabolism regulators and inflammation 
in 3T3-L1 preadipocytes after 7 days exposure to selenite (Figure 6). However, no effect was 
observed, indicating that selenite modulates the antioxidant status of the cells without affecting 
any key regulators of redox status or markers of energy metabolism and adipocytes 
differentiation. 
Adipocyte differentiation was characterised in function of changes on markers of redox status, 
inflammation and energy metabolism. In mature adipocytes, an increase in Pparg, Cebpa and 
Fabp4 mRNA expression, early markers of differentiation, was observed compared to 
preadipocytes, confirming the differentiation status of the cells and supporting previous study 
showing that the maturation of 3T3-L1 adipocytes is characterised by the increase in the markers 
of adipocytes differentiation [28]. A significant decrease in Gpx1 mRNA expression was 
observed, whereas no effect was observed on mRNA expression of regulators of redox status and 
inflammation such as Nrf2, Ho-1 or Cox2, compared to preadipocytes (Figure 7). These results 
suggest that adipocytes maturation and lipid deposition are characterised by a decrease in 
antioxidant capacity of the cell (GPX1), even if no changes were observed at the level of gene 
expression for Nrf2 transcription factor regulator of antioxidant defence and for Cox2 regulator of 
inflammation. Moreover, adipocytes maturation was characterised by an increase in Dio2 and 
Selenbp1 (Figure 7), reflecting a decrease in lipid catabolism and an increase in ROS production, 
respectively [26, 27]. These results support the potential role of oxidative stress in lipid 
accumulation and preadipocytes differentiation, which was confirmed by a significant increase in 
intracellular ROS levels in adipocytes compared to preadipocytes (Figure 5). In consistence with 
these results, a study by Kobayashi et al. showed that maturation of preadipocytes may be related 
to the increase in ROS, GPX was one of the antioxidant enzymes that was downregulated in 
hypertrophied adipose tissue and its cellular activity was decreased during maturation of 3T3-L1 
preadipocytes [38].  
In order to investigate the molecular mechanisms that are responsible for the decrease in 
adipocyte differentiation and lipid deposition induced by selenium and assessed by ORO staining 
(Figure 3), the effect of 200nM sodium selenite supplementation during the differentiation 
process on intracellular ROS levels and mRNA expression of different selenoproteins, markers of 
adipocytes differentiation, redox, and energy metabolism regulators and inflammation, was 
assessed. Selenium supplementation during differentiation caused a decrease in intracellular ROS 
levels (Figure 5), which was paralleled by an increase in Gpx1, Selenow, Selenop mRNA 
expressions and a decrease in Ho-1 mRNA expressions compared to non-supplemented 
adipocytes (Figure 8). Moreover, expression of markers of energy metabolism, inflammation and 
adipocytes differentiation (e.g. Dio2, Cox2 and Fapb4) was significantly reduced in adipocytes 
supplemented with sodium selenite.  These results are in agreement with previous publications: 
Kim et al., 2012 have stated that Cebpa mRNA was decreased during 3T3-L1 differentiation 
[43], whereas GPX1 and SELENOW in addition to SELENOH were shown to be the 
selenoproteins most affected by selenium in a dose-dependent manner in RAW264.7 cells after 
LPS stimulation [34].  
From the results obtained in this study, the following mechanism can be proposed: selenium 
supplementation, as inorganic selenite, during differentiation, causes a decrease in intracellular 
ROS levels which is matched by an increase in selenoproteins gene expression (Gpx1, Selenow, 
and Selenop), that induce an increase in the antioxidant capacity and a decrease in inflammatory 
mediators (Cox2) and subsequent decrease in energy metabolism and adipocyte differentiation 
markers (Dio2 and Fabp4), subsequently affecting adipocyte differentiation and reducing lipid 
deposition. The decrease in Ho-1 mRNA expression may be related to a feedback inhibition 
mechanism due to the increase in the antioxidant capacity of the cell due to selenium acting 
directly through selenoproteins (GPX1, SELENOW, and SELENOP) (Figure 9). To our 
knowledge, this is the first study to illustrate the underlying mechanism of sodium selenite in 
3T3-L1 cells through modulation of Gpx1, Selenow, Selenop, Ho-1, Dio2 and Fabp4 expression. 
Figure 9: Diagram of proposed mechanism for selenium modulation of adipogenesis. 
Sodium selenite causes an increase in selenoproteins expression (Gpx1, Selenow, and Selenop) 
that induces an increase in the antioxidant capacity of the cells and decrease in inflammatory 
mediators (Cox2) and subsequent decrease in adipocytes differentiation markers (Fabp4) at gene 
level, and, subsequently, affects adipocytes differentiation and lipid deposition. Created with 
BioRender.com  
Cebpa: CCAAT/enhancer-binding protein alpha; Cox2: cyclooxygenase 2; Dio2: type II iodothyronine deiodinase; 
Fapb4: fatty acid binding protein 4; Gpx1: glutathione peroxidase 1; Ho-1: heme oxygenase 1; MDI: hormone 
mixture; Pparg: peroxisome proliferator activated receptor gamma; ROS: reactive oxygen species; Selenop: 
selenoprotein P; Selenow: selenoprotein W. 
Some limitations are associated with this study which should be considered. The murine 3T3-L1 
cell line is widely used as in vitro model and well reflects the respective processes in primary 
preadipocytes undergoing adipocyte differentiation, compared to some available cell line, 
counteracting the translation of findings to humans. The concentration of sodium selenite chosen 
for this study (200nM) reflects the optimal amount of selenium required for maximum Gpx1 
expression in this cell culture system, and to ensure saturated biosynthesis of selenoproteins [44]. 
However, more studies are required to better identify the underlying mechanisms that regulate the 
tight U shape dose–response associated to selenium status and selenoprotein metabolism in 
adipocyte physiology and obesity pathogenesis [16]. 
In conclusion, the present study indicates that adipogenesis, as indicated by increase expression 
of adipogenesis mediators (Selenbp1, Pparg, Cebpa, and Fabp4) and presence of lipid 
accumulation, is modulated by oxidative stress (decrease in antioxidant mediators (Gpx1) and 
increase in ROS levels) and by selenium supplementation. Selenium supplementation 
successfully prevented adipogenesis in an in vitro system, as indicated by the decrease in lipid 
accumulation and ROS levels (key signalling molecules driving differentiation), and we 
hypothesise that this is mediated through the increase in the antioxidant capacity of the cells 
(Gpx1, Selenow, and Selenop), decrease in inflammatory mediators (Cox2) and decrease in 
adipogenesis mediators (Dio2 and Fabp4). If these findings are replicated in vivo and 
physiological relevance demonstrated, the present findings may provide valuable data for a novel 
dietary approach to prevent obesity. In addition, the present findings provide evidence-based 
rationale for dietary selenium supplementation of individuals whose selenium status is 
suboptimal, which might be very useful in obese COVID-19 patients as recent studies revealed 
that selenium status plays an important role in determining the host response to viral infections, 
and more specifically to SARS-CoV-2 infection [45-48]. As SARS-CoV-2 binds to the 
angiotensin converting enzyme 2 (ACE2) receptor that is expressed in adipose tissue and, 
therefore present at higher quantities in obese individuals, strategies that may reduce 
adipogenesis, such as the proposed role for selenium, might be important to study in view of the 
two current world epidemics, named obesity and COVID-19. Besides that, GPX1, which is 
affected by selenium concentrations, has been identified as having an important role in SARS-
CoV-2 infection. In addition to minimising the effects of oxidative stress, GPX1 appears to 
interact with the M
pro
 – a protein responsible for cleaving polyproteins that are involved with the
virus's structural components, blocking one of the primordial steps for the viral reproduction 
cycle [49]. 
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